🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 187 of 200 · A–Z by INN

  1. tranexamic

    NMPA: clinical trials

  2. tranexamic acid

    APO-TRANEXAMIC ACID Pfizer Australia Pty Ltd

    INJECTION FDA: approved · TGA: approved

  3. trans-resveratrol

    NMPA: clinical trials

  4. transplantation

    NMPA: clinical trials

  5. tranylcypromine

    PARNATE Amdipharm Mercury (Australia) Pty Limited

    TGA: approved

  6. tranylcypromine sulfate

    TRANYLCYPROMINE SULFATE

    ORAL FDA: approved

  7. trastuzumab

    HERZUMA Pfizer Australia Pty Ltd

    INTRAVENOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FD01

  8. trastuzumab and hyaluronidase-oysk

    HERCEPTIN HYLECTA

    SUBCUTANEOUS FDA: approved

  9. trastuzumab deruxtecan

    ENHERTU AstraZeneca

    EMA: approved · TGA: approved · PMDA: approved

    L01FD04

  10. trastuzumab duocarmazine

    JIVADCO

    EMA: application withdrawn

  11. trastuzumab emtansine

    KADCYLA Hoffmann-La Roche

    EMA: approved · TGA: approved · PMDA: approved

    L01FD03

  12. trastuzumab-anns

    KANJINTI

    SINGLE-DOSE FDA: approved

  13. trastuzumab-dkst

    OGIVRI

    INJECTION FDA: approved

  14. trastuzumab-dttb

    ONTRUZANT

    IV (INFUSION) FDA: approved

  15. trastuzumab-pkrb

    HERZUMA

    INJECTION FDA: approved

  16. trastuzumab-qyyp

    TRAZIMERA

    INJECTION FDA: approved

  17. trastuzumab-strf

    HERCESSI

    INJECTION FDA: approved

  18. travoprost

    TRAVATAN Novartis Pharmaceuticals

    OPHTHALMIC FDA: approved · EMA: approved · TGA: approved

    S01ED51

  19. travoprost + timolol

    DUOTRAV Novartis Pharmaceuticals

    TGA: approved

  20. trazodone

    NMPA: clinical trials

  21. trazodone hydrochloride

    TRAZODONE HYDROCHLORIDE Quantum Biopharma

    ORAL FDA: approved

  22. treatment

    NMPA: clinical trials

  23. trelagliptin succinate

    ZAFATEK

    PMDA: approved

  24. tremelimumab

    IMJUDO AstraZeneca

    EMA: approved · TGA: approved

    L01FX20

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources